Competition
- Main competitors
While there are a number of competitors in the space, few are well funded and none have reached sufficient scale to dominate the market either in Europe or the US.
Untitled
- Competitive moats
i. GTM
- Commonwealth/Brazil/Europe coverage: As many competitors are US-based, focusing on markets outside the US offers some white space for offers like Thymia’s. Thymia’s capabilities also work across different languages, enabling scalability. The UK and Brazil currently represent the bulk of Thymia’s pipeline, although Canada is also a strong market.
- Scientific credibility: The team has published multiple peer-reviewed papers and collaborates with many academic institutions.
ii. Technology
- Multi-modality: Many competitors focus on single-modality solutions, predominantly voice. In contrast, Thymia has a multi-modal approach; by integrating voice, video, and behavioral data, it offers a more comprehensive assessment of mental health conditions.
- Data moat:
- With an extensive dataset of about 12,000 individuals and over 700,000 minutes of data, Thymia has developed sophisticated AI models with an average AUC of 0.7, aiming for 0.8+.
- Thymia distinguishes between three levels of data quality: Poor (data collected 'in the wild' without clinical labels), Good (data curated through controlled online experiments with proper scientific protocols), and Excellent (data collected through thorough scientific protocols within a clinical context). Thymia's current dataset is of 'Good' quality, and they plan to evolve it to 'Excellent' by leveraging clinical partnerships or acquiring a healthcare provider.
- Intellectual property: The development of patented technologies strengthens Thymia’s position in the market.
Source